Participating in CIIE for four consecutive years, Zeiss brings cutting-edge technology to challenge the limits of imagination

Shanghai, October 27, 2021/PRNewswire/ - Zeiss will exhibit at the China International Import Expo (hereinafter referred to as the "CIIE") for the fourth consecutive year with the theme of "Challenge the Limits of Imagination"
.
This year, the Zeiss booth located in Hall 3 3A5-001 named its two exhibition areas with "Break through the boundaries of science, define future innovation" and "Challenge quality life, foresee more possibilities".

At that time, semiconductor manufacturing technology and industrial quality will be exhibited.

Maximilian Foerst, President of Zeiss Greater China, said: "This is the fourth time that Zeiss has participated in the CIIE, and it also marks the 175th anniversary of Zeiss
.
We hope to build a broader partnership through the platform of the CIIE and further integrate into China's "double".

"Circular' development pattern and local industrial ecosystem; at the same time, we also hope to review the history of Zeiss with partners from all walks of life, continue to promote local innovation cooperation, and continue to challenge the limits of imagination

Break through the boundaries of science and define future innovations

The "14th Five-Year Plan" clarifies the long-term goal of scientific research innovation and upgrading, and advanced microscopic imaging technology plays an indispensable role in promoting breakthroughs in scientific research projects

.

Axioscope 5 Optical Microscope / KINEVO 900 Robotic Surgical Microscope System

Semiconductor manufacturing technology and industrial quality solutions will also appear in the exhibition area
.
Zeiss is actively responding to local needs, constantly breaking through the technological limits and improving product quality through innovative solutions, and has made important contributions to the independent innovation and intelligent upgrading of China's manufacturing industry, including semiconductors

.

Challenge the quality of life, foresee more possibilities

As a major factor affecting the quality of life of the public, eye health is an important part of the joint construction of a human health community
.
In this sub-exhibition area, Zeiss will exhibit its femtosecond laser corneal refractive therapy machine VisuMax, three-dimensional positioning optics system VISUFIT®1000, refractive analyzer i.

Profiler® Plus, true color high-definition ultra-wide-angle fundus camera CLARUS 500, The Cirrus HD-OCT 5000 AngioPlex, a wide-angle vascular optical coherence tomography scanner, aims to bring the latest technology and the concept of "full life cycle eye health management" into the homes of ordinary people

CLARUS 500 true color high-definition ultra-wide-angle fundus camera / VisuMax femtosecond laser corneal refractive treatment machine

On the other hand, as the situation of myopia prevention and control in children and adolescents in China is becoming more and more severe, Zeiss has established a special team for myopia prevention and control in China to pay close attention to the high incidence of myopia in children and adolescents, the younger age of myopia, and the resulting eye diseases, schooling and employment, etc.
Problem
.
The company plans to create an overall solution for myopia prevention and control through a digital platform, an excellent operation center and a new myopia product matrix.

At the same time, it will further deepen cooperation with top local medical and scientific research institutions to jointly promote the standardization and precision of myopia diagnosis and treatment processes

As a pioneer in global optics and optoelectronics innovation, Zeiss has been close to local customers and industry development since entering China in 1957, achieving common growth in close cooperation
.
With global leading technology advantages, product portfolio and solutions covering the entire industry chain, and 175 years of innovative experience, Zeiss will continue to deepen the Chinese market and continue to create value for partners from all walks of life; at the same time, the company will be committed to satisfying the needs of the local market.

There are urgent needs in scientific research innovation, manufacturing upgrades and improving the quality of life

About Zeiss Group

Zeiss is a technological pioneer in the global optics and optoelectronic fields
.
In the last fiscal year, the Zeiss Group’s annual revenue totaled 6.

3 billion euros, covering the four major business sectors of semiconductor manufacturing technology, industrial quality and research, medical technology, and optical consumer goods markets (data as of September 30, 2020)

Zeiss is committed to developing, producing and marketing cutting-edge innovative industrial measurement and quality assurance solutions for customers, microscope solutions for the fields of biology and materials science, and medical technology solutions for ophthalmology and microsurgery diagnosis and treatment
.
Zeiss is also the industry benchmark for global lithography technology, and its technology is applied to the manufacture of semiconductor components by the chip industry
.
In addition, Zeiss brand glasses lenses, camera lenses and binoculars and other innovative products are also marketable worldwide
.

Zeiss's product portfolio is in line with the development trends of future growth areas such as digitalization, medical and smart manufacturing, and it also has a strong brand
.
With this, Zeiss is shaping the future of technology and continuously promoting the development of optics and related fields with its solutions
.
The company's sustainable and substantial investment in research and development has laid a solid foundation for the company's success, the continuous expansion of Zeiss technology and its leading position in the market
.
Zeiss invests 12% of its revenue in research and development-such a high level of research and development investment has a long tradition in Zeiss, which is also an investment in the future
.

Zeiss has approximately 34,000 employees worldwide, approximately 30 production bases, approximately 60 sales and service companies, and 27 R&D institutions in nearly 50 countries
.
The company was founded in Jena in 1846 and is headquartered in Oberkochen, Germany
.
Carl Zeiss AG is wholly owned by the Carl Zeiss Foundation (as of March 31, 2021), which is committed to promoting scientific development in Germany
.

For more information, please visit
.

ZEISS Greater China

Zeiss entered China in 1957.
At present, the Zeiss Group covers all business areas of semiconductor manufacturing technology, industrial quality solutions, research microscope solutions, medical technology, vision care and consumer optics in Greater China
.
China is one of the fast-growing markets of the Zeiss Group.
We have nearly 4,000 employees in Greater China.
We have 5 production bases and 6 sales and service centers in various regions to provide strong support for local customers and also for the global All related businesses provide production guarantee
.

ZEISS Greater China is headquartered in the Shanghai Pilot Free Trade Zone, with sales and service headquarters, application services and training centers, ZEISS industrial measurement production plants, and ZEISS’s first enterprise-level innovation R&D center outside Germany.
The central logistics and warehousing functions of the market fully support China's local R&D and production, actively expand cooperation areas, and deepen the Chinese market
.

For more information, please refer to the official website of Zeiss China: http:// Zeiss China